Early Experience of Combination Treatment of Sorafenib and Radiotherapy in Advanced Hepatocellular Carcinoma Patients

被引：1
|
作者：
Cha, J. [1 ]
Seong, J. [1 ]
Han, K. [1 ]
机构：
[1] Yonsei Univ Hlth Syst, Seoul, South Korea
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2010年 / 78卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2010.07.727
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S306 / S307
页数：2
相关论文
共 50 条
  • [21] Impact of HCV treatment in patients with advanced hepatocellular carcinoma on sorafenib.
    Herman, Michael
    Zhang, Yuhua
    Wang, Lisa
    Sim, Hao-Wen
    Knox, Jennifer J.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [22] Experience with sorafenib treatment of hepatocellular carcinoma (HCC) in patients in a Brazilian center
    Alves, Daniele Evaristo
    Alves, Rogerio
    Poletti, Paula
    Gampel, Otavio
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [23] Concurrent Sorafenib and Radiotherapy versus Radiotherapy Alone for Locally Advanced Hepatocellular Carcinoma
    Liu, C. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E580 - E580
  • [24] Early MRI response monitoring of patients with advanced hepatocellular carcinoma under treatment with the multikinase inhibitor sorafenib
    Horger, Marius
    Lauer, Ulrich M.
    Schraml, Christina
    Berg, Christoph P.
    Koppenhoefer, Ursula
    Claussen, Claus D.
    Gregor, Michael
    Bitzer, Michael
    BMC CANCER, 2009, 9
  • [25] Sorafenib in Combination With Transarterial Chemoembolization for the Treatment of Hepatocellular Carcinoma
    Geschwind, Jean-Francois H.
    Chapiro, Julius
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (08) : 585 - 587
  • [26] Early MRI response monitoring of patients with advanced hepatocellular carcinoma under treatment with the multikinase inhibitor sorafenib
    Marius Horger
    Ulrich M Lauer
    Christina Schraml
    Christoph P Berg
    Ursula Koppenhöfer
    Claus D Claussen
    Michael Gregor
    Michael Bitzer
    BMC Cancer, 9
  • [27] Comparison of treatment efficacy between sorafenib monotherapy and sorafenib-based combination therapy in advanced hepatocellular carcinoma
    Lee, Sangheun
    Kim, Seung Up
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    Kim, Ja Kyung
    Lee, Kwan Sik
    Han, Kwang-Hyub
    Chon, Chae Yoon
    HEPATOLOGY, 2012, 56 : 487A - 487A
  • [28] Sorafenib in combination with palliativ radiotherapy in metastatic hepatocellular carcinoma: a case report
    Gerum, S.
    Kolligs, F.
    Belka, C.
    Li, M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2014, 190 : 91 - 92
  • [29] Phase I study of everolimus in combination with sorafenib in patients with advanced hepatocellular carcinoma (HCC).
    Finn, R. S.
    Poon, R. T. P.
    Yau, T.
    Klumpen, H.
    Chen, L.
    Kang, Y.
    Kim, T.
    Gomez-Martin, C.
    Rodriguez-Lope, C.
    Kunz, T.
    Paquet, T.
    Asubonteng, K.
    Winkler, R. E.
    Anak, O.
    Sellami, D. B.
    Bruix, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [30] Role of sorafenib in the treatment of advanced hepatocellular carcinoma: An update
    Gauthier, Angela
    Ho, Mitchell
    HEPATOLOGY RESEARCH, 2013, 43 (02) : 147 - 154
12345